Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

Too much IKZF1 and Ikaros protein may cause alopecia areata.

A new genetic change causing early stop in the androgen receptor gene was found in a patient with androgen insensitivity syndrome.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

Researchers developed promising agents for prostate cancer imaging, with the best one showing high potential for clinical use.

Inhibiting retinoic acid activates WNT signaling, potentially aiding hair disorder and skin cancer treatments.

A genetic variant in "Blonde d'Aquitaine" calves causes death at birth due to a missing protein.

Urologists prescribe newer medications more often than primary care physicians, who could benefit from more education on treatment options.

Men with X-linked recessive ichthyosis often experience male-pattern baldness.

Different mutations in the 5 alpha-reductase-2 gene were found in affected individuals in the Dominican Republic, suggesting no common ancestry.

Autologous micrografting via the Rigenera® system shows promise in improving hair loss treatment.

Researchers found three different ways drugs work to treat hair loss from alopecia areata and identified key factors for personalized treatment.

Scientists made a carbon-14 labeled version of a drug with a 48% yield and over 99% purity.

Androgen receptors play a key role in male development and prostate cancer, with treatments targeting androgen action.

Ritlecitinib effectively regrows eyebrow and eyelash hair in alopecia areata, with 50 mg being the best dose.

Ruxolitinib cream may help treat severe hair loss in children.

DNA analysis can help tailor alopecia treatment.

AR-27 E-Chol siRNA can effectively promote hair regrowth for androgenetic alopecia.

Annurca apple extract may protect mouse hair from damage by chemotherapy and could help treat hair loss without promoting cancer growth.

ACKR2 helps prevent skin scarring and hair loss by controlling inflammation.

A rare gene variant causes sexual development issues in siblings, needing personalized treatment.

New drugs and therapies targeting specific pathways show promise in treating advanced prostate cancer.

Rac1 is essential for proper hair structure and color.

Ocu-miR-205 affects hair density in Rex rabbits by promoting cell changes and influencing hair follicle phases.

Certain genetic variants in the androgen receptor are linked to higher PSA levels, potentially affecting prostate cancer screening outcomes.

SQSTM1 is linked to increased risk of alopecia areata.

R-spondins and their receptors help increase bone growth and may be used to treat bone loss diseases.

CMG2 and TEM8 receptors have distinct roles in skin and growth disorders, affecting collagen breakdown and growth.

New drugs for rheumatoid arthritis show improvement but have side effects and are not a cure.

GTx-024 and Danazol affect the uterus like DHT, while GTx-007 has little impact.